Suspending vascular endothelial growth factor inhibitors in eyes with retinal vein occlusion.

چکیده

To identify predictors of continued discontinuation of vascular endothelial growth factor (VEGF) inhibitors for retinal vein occlusion (RVO) after it has been suspended. Eyes with RVO were identified in the Fight Retinal Blindness! registry that suspended VEGF inhibitors for ≥180 days when visual…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• شبکیه